| 
Results for oncology. Search took 0.07 seconds.
Chemotherapy Drug Triggers Fatal Allergic Reactions
in Allergies, on June 9, 2009
...ion.
The report has been presented at the 45th Annual Meeting of the American Society of Clinical Oncology held recently in Orlando, Fla.
...
Osteoporosis Drug Zometa Shrinks Breast Cancer Tumors
in Straightfromthedoc, on December 12, 2008
...e the risk of breast cancer recurrence as well," says Robert Coleman, MD, professor of medical oncology at the University of Sheffield in England.
He and colleagues put the drug to the test in 2...
Nanotubes Punching Holes in Cancer
in Nanotechbuzz, on August 28, 2008
Photo courtesy of iStockphoto, David Marchal
Everyone wants to cure cancer. Researchers at Stanford University are using carbon nanotubes to punch holes in tumor cells. Talk about targeted drug delivery! If chemotherapy can be delivered directly into cancer cells, then other healthy cells ma...
Nanomedicine Reviving a Cancer Drug
in Nanotechbuzz, on August 7, 2008
Many effective drugs never enter the market because of Toxicity and safety issues. An old cancer drug called TNP-470 was being researched in 1990, but clinical studies were stopped when neurologic toxicity was found in patients treated with this agent. Researchers at Children's Hospi...
Stopping the Spread of Cancer by Using Nanoparticle-Mediated Drug Delivery
in Nanotechbuzz, on July 22, 2008
When cancer spreads, this is called metastases and it can be devastating. Metastatic cancer means that the cancer has spread to other parts of the body, including organs like the liver, brain, bones, lungs, etc. Researchers are looking for ways to stop the spread of cancer. Using an integrin ...
Roche Made US$43.7B Bid For Remaining Genentech Shares
in The Biotech Weblog, on July 21, 2008
...Genentech that it doesn't own.
Genentech is a leading biotechnology company specializing in oncology drug. The combined powers as reported aims to 'foster innovation' for the healthc...
Fighting Cancer with Magnetic Nanoparticles
in Nanotechbuzz, on July 21, 2008
I've never been to Georgia Tech, but my dad studied there so I'd love to visit. Researchers at Georgia Tech have looked at using magnetic nanoparticles to remove cancer cells out of the body. Sounds almost like something from an X-Men movie. So much is happening in the world of cancer r...
Cooking Cancer Cells
in Nanotechbuzz, on July 18, 2008
© CarbonNYC
What happens when you take carbon nanotubes and coat cancer cells? Well, it gives you the ability to heat them up. What happens if you now expose those cells to near-infrared light? You may end up cooking those cells. This is what researchers at the University of Texas Southwester...
So What is Apoptosis?
in Nanotechbuzz, on June 19, 2008
Photo courtesy of iStockphoto, Sven Hoppe
If you've been following any nanotechnology news, you've probably seen this term called "apoptosis." What does this word mean? Programmed cell death. That's right. Our cells know when they should destroy themselves. If a human ...
NCI Alliance for Nanotechnology in Cancer
in Nanotechbuzz, on June 17, 2008
...his includes nanotechnology research aimed at improving patient outcomes. The phrase "nanotech oncology" is a buzzword these days because of the immense amount of research that is being cond...
Oncology Diagnostics By AviaraDx
in The Biotech Weblog, on April 14, 2008
...on cancer diagnostics are what AviaraDx, Inc. brought to the market.
© meneldur
Two new oncology tests have been launched for the classification of metastatic cancer and identification of p...
Roche Invests $387 million in Biotech Drug Research
in The Biotech Weblog, on January 28, 2008
...exploited to its full potential in the development and production of biopharmaceuticals mainly for oncology applications .
Source: Roche ...
Lapatinib (Tykerb) -Capecitabine (Xeloda) Combo Shrinks Breast Cancer Metastases in the Brain
in Straightfromthedoc, on December 18, 2007
...at the San Antonio Breast Cancer Symposium.
As reported Nancy Lin, MD, of Dana-Farber's Breast Oncology Center:
"In the extension trial, capecitabine was added to lapatinib in 49 patients ...
Nexavar® (sorafenib), FDA-Approved for Inoperable Hepatocellular Carcinoma
in Straightfromthedoc, on November 21, 2007
...e cancer is inoperable.
According to Robert Justice, M.D., director of FDA's division of drug oncology products:
"In a randomized clinical trial, the group of patients with inoperable he...
GPRC5A: Lung Cancer Tumor-Suppressor Gene, Identified in Mouse Models
in Straightfromthedoc, on November 16, 2007
...euben Lotan, Ph.D., professor in M. D. Anderson's Department of Thoracic/ Head and Neck Medical Oncology:
"In humans, lung adenocarcinomas are the most common type of lung cancer and the ma...
November Is Also Pancreatic Cancer Awareness Month
in Straightfromthedoc, on November 16, 2007
...er deaths in the U.S.
From Moffitt Cancer Center :
Moffitt Cancer Center's Gastrointestinal Oncology Program has an early detection and screening program for pancreatic cancer. This program is...
Smoking: Not Associated To Advanced Breast Cancer?
in Straightfromthedoc, on October 29, 2007
...more than 6,000 patients presented yesterday at the American Society for Therapeutic Radiology and Oncology 's 49th Annual Meeting in Los Angeles .
We hypothesized that tobacco use could ...
Three Drinks a Day?
in Well Woman Blog, on September 28, 2007
...ed risk factor," said Patrick Maisonneuve, head of epidemiology at the European Institute of Oncology in Italy, who was not connected to the study.
"Women drinking wine because they ...
Sugar Substitute, Aspartame and Cancer
in Daily Diabetic, on August 12, 2007
...ar because of its implication to cancer .
Can aspartame really cause cancer?
Clinical oncology dietitian Dena McDowell, MS, RD answers that very question in a scrutinizing review of aspa...
GSK's Atriance® (nelarabine) Received Positive Opinion in EU
in The Biotech Weblog, on June 29, 2007
...hoblastic lymphoma (LBL): T-ALL and T-LBL.
According to Paolo Paoletti, SVP and Global Head of Oncology Research and Development, GSK:
"Nelarabine may offer some patients the chance to ...
Shark Cartilage Compound is No Lung Cancer Therapy
in Straightfromthedoc, on June 6, 2007
...Lu, M.D.(associate professor in M. D. Anderson's Department of Thoracic/Head and Neck Medical Oncology ).
Phases I and II studies of this extract have suggested some benefit to patients wit...
Flaxseed Reduces Prostate Tumor Growth
in Straightfromthedoc, on June 5, 2007
...ese findings have been reported at the recent annual meeting of the American Society of Clinical Oncology in Chicago.
Read the full report from Duke University Medical Center .
[In photo: Flaxs...
TYKERB®: GlaxoSmithKline's Breast Cancer Drug, Approved by the FDA
in The Biotech Weblog, on March 16, 2007
...ed collaborative research studies.
According to Paolo Paoletti, MD, Senior Vice President of the Oncology Medicine Development Center at GSK:
"Tykerb is a significant breakthrough for women wi...
USFDA Approved GlaxoSmithKline's Breast Cancer Drug TYKERB®
in Straightfromthedoc, on March 15, 2007
...is particular patient population.
According to Paolo Paoletti, MD, Senior Vice President of the Oncology Medicine Development Center at GSK:
"Tykerb is a significant breakthrough for women wit...
Biomarker Test for Bladder Cancer Recurrence and Survival
in The Biotech Weblog, on February 20, 2007
... might not need unnecessary chemotherapy."
The study has been published online in The Lancet Oncology . ...
Protein Biomarkers Predict Bladder Cancer Recurrence and Survival
in The Biotech Weblog, on February 6, 2007
... test positive for the mutated biomarkers, are available online in an upcoming issue of The Lancet Oncology .
The proteins Bcl-2, caspase-3, P53 and survivin --proteins known to regulate apoptosis -...
First Autologous Cord Blood Transplant for Childhood Leukemia Worldwide, Recently Announced by CorCell (a Cord Blood America Company)
in Straightfromthedoc, on January 5, 2007
... for that child.]
As stated by Jack Goldberg, MD, CorCell Medical Director and Chief of Hematology Oncology at the University of Pennsylvania Health System , PennPresbyterian:
"This is the fi...
Prostate Cancer Treatment May Increase Diabetes, Heart Disease Risks
in Daily Diabetic, on October 27, 2006
...vels.
The researchers' findings appear in the September 20th issue of the Journal of Clinical Oncology.
Over a third of men were treated with a GnRH Agonist , the report indicates. Use of...
Mayo Clinic found that Preventive Ovary Removal is linked to Early Death in Younger Women
in Straightfromthedoc, on September 23, 2006
...According to a new Mayo Clinic study that will be published in the October 1 issue of The Lancet Oncology , death rates rise when women under 45 years old undergo bilateral ovariectomy and do not ...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...y's top picks were:
MedImmune : Products include biopharmaceuticals for infectious diseases, oncology and immunology : Flumist® , Synagis® , Ethyol® , Cytogam®
Genentech : Biophar...
Using Hair Dye May Increase Lymphoma Risk
in Straightfromthedoc, on July 6, 2006
... an article on CNN.com, the research was led by Dr. Silvia de Sanjose at the Catalan Institute of Oncology in Barcelona, Spain. Dr. de Sanjose and her colleagues contributed their findings in an art...
Bayer Takes Over Schering
in The Biotech Weblog, on June 16, 2006
...ing to Bayer, Merck says it is now keen to cooperate with Bayer , particularly in in the fields of oncology, Cardiology or diabetes.
The cost of the deal, which reached almost $22 billion, is ...
PET and CT Scan Combo For Accurate Cancer Treatment
in Straightfromthedoc, on May 4, 2006
...n the combined tomography is published in the May issue of the International Journal of Radiation, Oncology, Biology and Physics , the official journal of ASTRO , the American Society for Therapeuti...
5th Annual Antibody World Summit
in The Biotech Weblog, on April 29, 2006
...vent will cover three tracks concurrently:
The Antibody Discovery & Development
mAbs in Oncology
Antibody Manufacturing & Production
Click here for more information. Registr...
Serono Seeks Acquisitions Or Merger Instead of Take-Over
in The Biotech Weblog, on April 11, 2006
...ased UCB. According to Chief Financial Officer Stuart Grant, "acquisitions were most likely in oncology and auto-immune disease, the areas where the firm is currently strongest", but that he...
Okay, So Maybe Wi-Fi Doesn't Cause Cancer...
in The Wireless Weblog, on March 1, 2006
..."I think the probability of that is nil," says Kelly Clifton, Professor Emeritus of Human Oncology in UW-Madison's medical school. "The wavelength of the wireless transmission makes...
New Virus Found In Prostate Tumors Suggests Prostate Cancer May Be An Infectious Disease
in The Biotech Weblog, on February 27, 2006
...
In a report presented at an American Society of Clinical Oncology meeting, scientists from the Cleveland Clinic suggest that prostate cancer, especially in patients who exhibit a certian typ...
Avastin for pancreatic tumor: clinical trial underway
in Straightfromthedoc, on February 23, 2006
... or organs in the body.
The results appeared in the February 2006 issue of the Annals of Surgical Oncology .
"Our findings from the previous study suggest that the combination of chemotherapy ...
Rad9 Inactivation Increase Efficacy Of Radiation In Cancer Therapy
in The Biotech Weblog, on February 20, 2006
...apeutic advantage," says senior author Tej K. Pandita, Ph.D., associate professor of radiation oncology and on the faculty of the Siteman Cancer Center at Washington University School of Medicine...
avastin: promising but expensive cancer drug
in Straightfromthedoc, on February 17, 2006
The drug Avastin has been widely used for the treatment of colon cancer. Now it is a potential new treatment for lung and breast cancer too. However many are already cringing at the price that its maker, Genentech , plans to charge for it: about $100,000 a year; a price about double the curre...
treatment method improves survival for advanced laryngeal cancer
in Straightfromthedoc, on February 8, 2006
... the U-M Medical School.
The study appears in the Feb. 1, 2006 issue of the Journal of Clinical Oncology .
...
Anticancer Drug Against Hodgkin's and Leukemia Granted Orphan Drug Status
in The Biotech Weblog, on January 31, 2006
...al research program to advance into human trials by GPC Biotech , a Germany-based firm focusing on oncology. Read the full press release from GPC Biotech . ...
BIO-Asia Partnering Conference
in The Biotech Weblog, on January 28, 2006
... partnering and licensing
trends on a global scale
challenges and opportunities in building an oncology company through partnerships and acquisitions
business models that best address the produ...
Merck Acquires Survac
in The Biotech Weblog, on November 24, 2005
...tic cancer vaccines.
Dr. Wolfgang Wein, senior vice president for Merck's commercial unit oncology says: "A key element of Merck's strategy in oncology is to expand our clinical pipelin...
Sirna Therapeutics Patents Vector Expressed siRNA Against Huntington's Disease
in The Biotech Weblog, on October 5, 2005
...neration (AMD), hepatitis B and C, dermatology, asthma, Huntington's Disease, diabetes and oncology.
Read the press release about the patent here .
Image Credits: Lydia Kibiuk, � 1997 Lyd...
Asia Medical Congress in BIOPOLIS
in The Biotech Weblog, on September 1, 2005
...November, 2005, operating on the theme, "Focus on Future research, diagnostics and therapy in Oncology:
Translating Research into the Clinic" .
For registration, programme and other detail...